Anastasia Romanovna Kabaeva

Anastasia Romanovna Kabaeva

Auto-generated profile, based on publicly available information

Anastasia Romanovna Kabaeva

Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
PDF file
VPVladimir Parfenov
Vladimir Parfenov
VZVladimir Vladimirovich Zakharov
Vladimir Vladimirovich Zakharov
AKAnastasia Romanovna Kabaeva
Anastasia Romanovna Kabaeva
NVNatalya Vasilyevna Vakhnina
Natalya Vasilyevna Vakhnina
Over 44 million people suffer from dementia around the world. Researchers estimated that there will be 48.1 million people with dementia by 2020 and 90.3 million by 2040. In addition to dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) relate to cognitive impairment. It has been established that MCI precedes dementia, however the significance of SCD is still unclear. Recent studies suggest that SCD could be a risk factor for objective cognitive impairment. SCD is defined as а self-estimated decline in cognitive capacity in comparison to an individual’s previous level of functioning, which cannot be determined by neuropsychological tests. Objectives: To perform a systematic review of prospective longitudinal cohort studies that assessed the risk of MCI and dementia among people with SCD. Methods: A search was carried out for all available peer-reviewed articles in English related to SCD in PubMed and PsychINFO databases from database initiation through January 2020. The keywords used for the search were ‘subjective cognitive (or memory) impairment (or decline or complaints)’. Three authors separately determined the inclusion or exclusion of all articles retrieved for full-text evaluation. Results: The chance of progression to dementia in the SCD group was 2.17 (95% confidence interval [95%CI] 1.53‒3.07; p<0.05) compared to normal aging. Furthermore, the SCD group was 2.15 times more likely to progress to MCI than the group without SCD (95%CI 1.39‒3.30; p=0.005). Conclusions: SCD might precede cognitive impairment, however, more detailed longitudinal studies should be conducted.

2 April 2018 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
SVS. V. Verbitskaya
S. V. Verbitskaya
VPVladimir Parfenov
Vladimir Parfenov
VRVladimir Reshetnikov
Vladimir Reshetnikov
VKV. V. Kozlov
V. V. Kozlov
AKA. R. Kabaeva
A. R. Kabaeva
Post-stroke cognitive impairment (results of a 5-year follow-up)

1 January 2021 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
EKElena Anatolevna Katunina
Elena Anatolevna Katunina
OBO.V. Boyko
O.V. Boyko
NSN.N. Shipilova
N.N. Shipilova
AKA.R. Kabaeva
A.R. Kabaeva
ABAlexey Boyko
Alexey Boyko
Экстрапирамидные нарушения и рассеянный склероз (РС) — достаточно редкое сочетание. Вероятность комбинации РС и болезни Паркинсона составляет <1 случая на 12,5 млн. Всего в литературе описано 42 случая совместного развития данной патологии. У всех описанных больных отсутствовали первоначальные изменения базальных ганглиев на МРТ, а развитие РС отмечалось через 1—8 лет. Обсуждаются возможные общие звенья патогенеза нейродегенеративного заболевания и РС, а также кумулятивный эффект 2 заболеваний на выраженность аксональной дегенерации и нейрональных потерь. Представлено описание клинического случая сочетания раннего начала болезни Паркинсона и ремиттирующего РС.

1 January 2019 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
PDF file
ASAnastasiya Sviridova
Anastasiya Sviridova
AKA. R. Kabaeva
A. R. Kabaeva
VRV. S. Rogovskii
V. S. Rogovskii
MKM. Kh. Kozhieva
M. Kh. Kozhieva
MMMikhail Melnikov
Mikhail Melnikov
ABAlexey Boyko
Alexey Boyko
Biogenic amines are key mediators of neuroimmune interaction and may influence on multiple sclerosis (MS) pathogenesis and MS course. At the same time, the role of biogenic amines in immunoregulation of early stages of demyelination, in particular clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS) is still unclear. This literature review addresses a role of norepinephrine in the regulation of neuroimmune interactions in the early stages of the demyelination. Neuropsychological disorders, immunological characteristics, gut-brain axis as well as the role of norepinephrine in these interactions in patients with CIS, RIS and early MS are discussed.

17 April 2022 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
NBNatalia Baulina
Natalia Baulina
AKA. R. Kabaeva
A. R. Kabaeva
ABAlexey Boyko
Alexey Boyko
OFOlga Favorova
Olga Favorova
The role of miRNAs – small, regulatory, noncoding RNAs – in the multiple sclerosis (MS) development is being intensively investigated. Previously, we the first who observed a significant increase in the expression of 26 microRNA genes localized in the DLK1-DIO3 locus in men with relapsing-remitting MS (RRMS) in peripheral blood mononuclear cells (PBMCs), using RNA sequencing.Objective: to evaluate the possible involvement of miRNAs in the regulation of the activity of the pathological process in RRMS by comparing the miRNA genes expression levels from this locus in patients in remission, relapse, and healthy individuals, separately for men and women.Patients and methods. Analysis of miR-431-5p, miR-127-3p, miR-379, miR-376c, miR-381, miR-410 and miR-656-3p microRNA expression was performed by reverse transcription and subsequent real-time polymerase chain reaction in PBMCs of 16 patients in the relapse stage, 20 patients in remission who did not receive immunomodulatory drugs, and 20 healthy individuals.Results and discussion. The expression levels of all studied miRNAs did not differ in patients in remission and relapse stages, in men and women. At the same time, men (in remission and relapse) showed a significant increase in the levels of all miRNAs compared with healthy men; in women, no changes in expression were observed. A high level of correlation of miRNA expression from the DLK1-DIO3 locus was shown in both patients and healthy individuals from the control group, regardless of gender. Coexpression was observed not only for miRNA genes from the same cluster (14q32.2 or 14q32.31), but also for genes from different clusters.Conclusion. The miRNAs genes from the DLK1-DIO3 locus are involved in the pathophysiology of RMS onset, but not in the processes associated with the transition from remission to relapses. The high consistency of miRNA expression, regardless of the localization of their genes within this region, suggests the presense of a common mechanism that regulates their transcription.

1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
NBNatalia Baulina
Natalia Baulina
AKA.R. Kabaeva
A.R. Kabaeva
ABAlexey Boyko
Alexey Boyko
OFOlga Favorova
Olga Favorova
ЦЕЛЬ ИССЛЕДОВАНИЯ Анализ экспрессии нескольких ранее не изученных микроРНК из локуса DLK1-DIO3 в мононуклеарных клетках крови (МНК) и клеточных субпопуляциях CD14+ и CD4+ у больных ремиттирующим рассеянным склерозом (РРС), а также здоровых индивидов. МАТЕРИАЛ И МЕТОДЫ Анализ экспрессии микроРНК проводили в МНК, CD14+ и CD4+ клетках 14 больных РРС, не принимавших иммуномодулирующие препараты, и 14 индивидов без аутоиммунных и воспалительных заболеваний методом обратной транскрипции с последующей ПЦР в реальном времени. РЕЗУЛЬТАТЫ Уровни экспрессии 10 выбранных на основании разных критериев микроРНК были значимо выше в МНК у мужчин, больных РРС, по сравнению со здоровыми мужчинами; у женщин их экспрессия не отличалась при аналогичном сравнении. В CD14+ и CD4+ клетках массовых однонаправленных изменений экспрессии этих микроРНК у мужчин с РРС не наблюдали. Высокой согласованности экспрессии пар микроРНК обнаружено не было. ЗАКЛЮЧЕНИЕ При анализе МНК показана вовлеченность еще 10 микроРНК, кодируемых генами из локуса DLK1-DIO3, в развитии РРС. Основной наблюдаемый эффект возрастания уровней экспрессии этих микроРНК у мужчин с РРС по сравнению со здоровыми мужчинами достигается не за счет вклада CD14+ и CD4+ клеток. Это открывает возможности для исследования вовлеченности микроРНК из других клеточных субпопуляций МНК в патологические процессы при РРС.